We’d like to introduce you to the fellow above, whose name is Jae. When asked what area of study she specializes in, she only ...

In a 7-2 decision, the Supreme Court agreed with HHS's narrow interpretation of how to pay hospitals for treating low-income patients.

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV medicines.

BridgeBio’s recently approved heart drug blew past expectations as the biotech continues to see a strong demand for its first major commercial product.

Funding for a landmark health study, the Women's Health Initiative, was cut then reportedly restored, but researchers are ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

As of last week, Chris Klomp is in charge of the Center for Medicare. Unlike predecessors, he’s not a policy wonk. Klomp was ...

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

There is common ground. Most adults favor: Preventing chronic diseases (Republicans 86%, Democrats 91%) Protecting against ...

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...